๐ About
Always check the BNF link here for up-to-date prescribing guidance.
- Eplerenone is a selective aldosterone receptor antagonist used in heart failure management.
- It has similar actions to spironolactone but fewer anti-androgenic side effects (e.g. gynaecomastia).
โ๏ธ Mode of Action
- Competitively binds to aldosterone receptors in the distal nephron.
- Reduces sodium and water retention, lowers preload/afterload, and prevents myocardial remodelling.
๐ Indications
- Licensed: Adjunct in chronic heart failure, especially post-MI with LV dysfunction or CCF Class IIIโIV.
- Off-label: Sometimes used in resistant hypertension (consult specialist guidance).
๐ Dose
- Start: 25 mg OD.
- Titrate up to 50 mg OD depending on potassium & renal function.
- Monitor U&E at baseline, 1 week, and 1 month, then regularly.
โ ๏ธ Interactions
๐จ Avoid co-administration with other potassium-sparing drugs โ risk of severe hyperkalaemia.
- Drugs increasing Kโบ: Trimethoprim, Ciclosporin, Tacrolimus.
- Antiarrhythmics: Amiodarone, Diltiazem, Verapamil.
- Antimicrobials (CYP3A4 inhibitors): Ketoconazole, Itraconazole, Clarithromycin, Erythromycin, Ritonavir.
- Other: Digoxin (โ toxicity), Lithium, Rifampicin, Carbamazepine, Phenytoin.
โ Contraindications & Cautions
- Severe renal impairment (eGFR <30 mL/min/1.73mยฒ).
- Baseline serum potassium >5.0 mmol/L.
- Concomitant use with potassium supplements or strong CYP3A4 inhibitors.
- Caution in pregnancy & breastfeeding.
๐ฅ Side Effects
- Hyperkalaemia โก โ most serious (requires monitoring).
- Dizziness & hypotension.
- GI upset: diarrhoea, nausea.
- Skin rash (rare).
๐ก Clinical Pearls
- Eplerenone is preferred over spironolactone if patients develop gynaecomastia.
- Always check renal function & potassium before starting and during therapy.
- Improves survival in patients post-MI with LV systolic dysfunction when added to ACEi + beta-blocker.